WAKUNAGA PHARMACEUTICAL CO., LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 5250
 
  
 
C07D HETEROCYCLIC COMPOUNDS 5157
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 198
 
  
 
C07K PEPTIDES 1135
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 198
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 1124

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

  • No Recent Publications to Display

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9079961 GPIIIa geneMay 26, 08Jul 14, 15[C07H, C12Q, C12P, G01N, C07K]
8975411 Therapeutic agent for neurological diseasesJul 15, 11Mar 10, 15[C07D]
8846089 Sugar-coated preparation and production method for the sameMay 30, 12Sep 30, 14[A61K]
7846475 Soft capsulesJul 03, 02Dec 07, 10[A61K]
7129232 Cephem compoundsOct 30, 03Oct 31, 06[C07D]
6156903 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective componentsJun 10, 99Dec 05, 00[C07D]
6133284 Pyridonecarboxylic acid derivatives or their salts, and antibacterial agents containing the same as their effective componentsJun 10, 99Oct 17, 00[A61K, C07D]
5998436 Pyridonecarboxylic acid derivatives or their salts and antibacterial agent comprising the same as the active ingredientMar 20, 98Dec 07, 99[A61K, C07D]

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
8173684 Pyridone derivatives as p38α MAPK inhibitorsExpiredMay 02, 08May 08, 12[A61K, C07D]
8008028 Panel cell used for granulocyte antibody detectionExpiredMar 13, 07Aug 30, 11[C12N, G01N]
2010/0285,147 CRUDE DRUG EXTRACT-BLENDED LIQUID MEDICINEAbandonedJul 31, 08Nov 11, 10[A61K, A61P]
2010/0159,615 IMMUNOLOGICAL DETECTION METHOD USING AVIAN ANTIBODYAbandonedDec 27, 07Jun 24, 10[G01N]
7713997 Pyridonecarboxylic acid derivatives or salts thereofExpiredNov 17, 05May 11, 10[A61K, C07D]
7651706 Liquid preparation containing crude-drug extractExpiredSep 12, 02Jan 26, 10[A61K]
2009/0042,856 PYRIDAZINONE DERIVATIVES USED FOR THE TREATMENT OF PAINAbandonedAug 31, 06Feb 12, 09[A61K, C07D, A61P]
2009/0012,054 Cephem Compounds and Use as Antimicrobial AgentsAbandonedMar 16, 07Jan 08, 09[A61K, C07D, A61P]
2008/0311,571 Nucleic Acid Fragments for Detecting Nucleic Acid and Method for Detecting Nucleic AcidAbandonedNov 21, 05Dec 18, 08[C07H, C12Q]
2008/0274,213 Drug for Ameliorating Male Climacteric DisordersAbandonedMay 31, 05Nov 06, 08[A61K, A61P]
2007/0122,452 Fat compositionAbandonedDec 21, 04May 31, 07[A61K, C07F]
7192943 Cephem compoundsExpiredSep 17, 04Mar 20, 07[C07D]
7179801 Cephem compoundsExpiredApr 24, 02Feb 20, 07[C07D]
2007/0037,786 Cephem compoundsAbandonedOct 24, 06Feb 15, 07[A61K, C07D]
2006/0182,798 Composition for gelatin coating, gelatin coating, and preparation using the sameAbandonedJan 26, 06Aug 17, 06[A61K]
2006/0153,909 Hard capsuleAbandonedJun 25, 04Jul 13, 06[A61K]
2006/0124,695 Stable liquid preparationAbandonedJun 25, 04Jun 15, 06[A47J]
2006/0118,003 Light-blocking agent and film-forming compositionAbandonedDec 16, 03Jun 08, 06[C09C]
2005/0112,189 Hard capsulesAbandonedJun 25, 04May 26, 05[A61K]
6858625 Quinolinecarboxylic acid derivative or salts thereofExpiredDec 31, 01Feb 22, 05[A61K, C07D]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.